Jaccard, M. Et Al. 2020. Urethra-sparing stereotactic body radiotherapy for prostate cancer: quality assuranceof a randomized phase II trial.. International journal of radiation oncology, biology, physics , vol.108 , 1047-1054.

Jaccard, M., Zilli, T., Dubouloz, A., Escude, L., Jorcano, S., Linthout, N., ... Bral, S.(2020). Urethra-sparing stereotactic body radiotherapy for prostate cancer: quality assuranceof a randomized phase II trial.. International journal of radiation oncology, biology, physics , vol.108, 1047-1054.

Jaccard, M Et Al. "Urethra-sparing stereotactic body radiotherapy for prostate cancer: quality assuranceof a randomized phase II trial.," International journal of radiation oncology, biology, physics , vol.108, 1047-1054, 2020

Jaccard, M Et Al. "Urethra-sparing stereotactic body radiotherapy for prostate cancer: quality assuranceof a randomized phase II trial.." International journal of radiation oncology, biology, physics , vol.108, pp.1047-1054, 2020

Jaccard, M. Et Al. (2020) . "Urethra-sparing stereotactic body radiotherapy for prostate cancer: quality assuranceof a randomized phase II trial.." International journal of radiation oncology, biology, physics , vol.108, pp.1047-1054.

@article{article, author={M Jaccard Et Al. }, title={Urethra-sparing stereotactic body radiotherapy for prostate cancer: quality assuranceof a randomized phase II trial.}, journal={International journal of radiation oncology, biology, physics}, year=2020, pages={1047-1054} }